Reverse atrial electrical remodeling: A systematic review by Pang, Helen et al.
625www.cardiologyjournal.org
REVIEW ARTICLE
Cardiology Journal
2011, Vol. 18, No. 6, pp. 625–631
10.5603/CJ.2011.0025
Copyright © 2011 Via Medica
ISSN 1897–5593
Address for correspondence: Dr. Adrian Baranchuk, MD, FACC, Associate Professor of Medicine, Cardiac Electrophysiology
and Pacing, Director, EP Training Program, Kingston General Hospital, FAPC 3, Queen’s University, 76 Stuart Street,
K7L 2V7, Kingston, ON, Canada, tel: 613 549 6666 ext. 3801, fax: 613 548 1387, e-mail: barancha@kgh.kari.net
Received: 21.10.2011 Accepted: 22.10.2011
Reverse atrial electrical remodeling:
A systematic review
Helen Pang1, Ricardo Ronderos2, Andrés Ricardo Pérez-Riera3,
Francisco Femenía4, Adrian Baranchuk1
1Cardiology Division, Kingston General Hospital, Queen’s University, Kingston, Ontario, Canada
2Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina
3ABC Faculty of Medicine, Sao Paulo, Brazil
4Unidad de Arritmias, Departamento de Cardiología, Hospital Espańol de Mendoza, Argentina
Abstract
Atrial remodeling is a term introduced in 1995 to describe alterations in atrial structure or
function. Atrial electrical remodeling is characterized by a reduction of refractory period and
action potential duration, dispersion in refractoriness, and a reduction in conduction velocity
of impulse propagation. Numerous animal and human studies have demonstrated that atrial
electrical remodeling impairs normal atrial conduction and provides an environment for
ectopic and re-entrant activity, thus creating a substrate for the initiation or maintenance of
atrial fibrillation. Interestingly, atrial electrical remodeling has been shown to be reversible. In
this systematic review, we examine the occurrence of reverse atrial electrical remodeling in
various clinical settings. (Cardiol J 2011; 18, 6: 625–631)
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Introduction to atrial remodeling
Atrial remodeling is a term used to describe the
phenomenon of persistent alterations in the pro-
perties or functions of atrial tissue. The concept of
atrial remodeling was introduced as early as 1995
by Wijffels et al. [1], who demonstrated that atrial
fibrillation (AF) in goats induces atrial functional
alterations that favour the maintenance of AF. As
they put it: “Atrial fibrillation begets atrial fibrilla-
tion.” Atrial remodeling has significantly enhanced
our understanding of the pathophysiology implicat-
ed in atrial arrhythmias. Altered atrial structure or
function increases the likelihood of ectopic and re-
entrant activity [2, 3], thus providing a substrate for
the development of arrhythmias. The role of atrial
remodeling specifically in AF has received increas-
ing attention in recent literature. The rapid atrial
rates in AF have been shown in a canine model to
induce an abbreviation of atrial effective refractory
period (ERP) and action potential duration (APD),
subsequently favoring the initiation or maintenance
of AF [4].
On the other hand, congestive heart failure
(CHF) promotes AF through a different paradigm
— atrial structural remodeling. An earlier study by
Li et al. [5] in a canine model of CHF reported un-
changed ERP and suggested the promotion of AF
primarily through the disruption of atrial conduc-
tion by interstitial fibrosis.
Reduced atrial contractility, the development
of fibrosis, and atrial enlargement are the key cha-
racteristics of atrial structural remodeling. Patients
with chronic AF demonstrate a reduction of ~75%
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in the contractile force of their right atrial appen-
dages compared to those without AF [6, 7], which
may result from the loss of sarcomeres or reduced
Ca2+ release from the sarcoplasmic reticulum [3].
Furthermore, transgenic mice with cardiac-restrict-
ed overexpression of angiotensin-converting enzy-
me [8] or transforming growth factor-beta1 (TGF-b1)
[9] have shown increased atrial fibrosis and AF
propensity, highlighting the pathophysiological im-
portance of angiotensin-II and TGF-b1. In addition
to the changes on a microscopic level, echocardio-
graphy in a canine model revealed biatrial enlarge-
ment after rapid atrial pacing for six weeks [4]. An
increased atrial size is able to accommodate more
re-entry circuits and is an important clinical predic-
tor for AF development and maintenance [10], as
well as AF recurrence following catheter ablation
[11] or cardioversion [12]. In the presence of CHF,
interstitial fibrosis is apparently the most important
phenomenon which interferes with local atrial con-
duction by interrupting the arrangement of cardio-
myocytes. While a canine model of CHF has shown
interstitial fibrosis to be associated with increased
conduction heterogeneity [5], impaired conduction
and increased susceptibility to AF have also been
documented in CHF patients [13]. Upon recovery
from CHF in the canine model, fibrosis and conduc-
tion abnormalities did not reverse, and a substrate
for AF remained despite the reversal of electrical
remodeling, suggesting that structural remodeling
is an important contributor to the AF substrate in
CHF [14]. Although seemingly detrimental, struc-
tural remodeling may in fact be an adaptive response
to the underlying cardiac disease.
Atrial electrical remodeling in AF is best rep-
resented by the shortening of atrial ERP and the
loss of rate adaptation [1, 4], but also includes spa-
tial heterogeneity of atrial refractoriness and con-
duction velocity [1, 15, 16]. The concept of atrial
electrical remodeling was first introduced by
Wijffels et al. [1] and Morillo et al. [4] in 1995, who
concomitantly demonstrated a shortening of atrial
ERP in goats with sustained AF and dogs with ra-
pid atrial pacing, respectively. Increases in P-wave
duration, dispersion in refractoriness, and vulnera-
bility to AF were also observed [4]. Refractory pe-
riod abbreviation is attributable to the down-regu-
lation of L-type Ca2+ current (ICaL) as a result of Ca2+
accumulation within atrial myocytes due to rapid
atrial activation [17, 18]. The abbreviation in refrac-
tory periods shortens the wavelengths of atrial im-
pulse, favoring the occurrence of multiple wavelet
re-entry and subsequently increasing the suscep-
tibility to AF or stability of AF [3, 19]. Increased
dispersion of atrial refractoriness has been docu-
mented in paroxysmal AF patients [21] and patients
with early postoperative-AF after coronary artery
bypass grafting [22] and is associated with their AF
inducibility. Interestingly, electrical remodeling
that promotes AF in the presence of CHF is mark-
edly different: prolonged P-wave duration and ERP,
and unchanged rate adaptation [23].
The fundamental basis of electrical remodel-
ing is the alteration in the expressions or activity
of ion channels — ionic remodeling. Reduction in
ICaL, reportedly as much as 70% in atrial myocytes
of AF patients [17], is an important contributor to
the abbreviation of APD and atrial refractoriness
[17, 18, 20]. The down-regulation of ICaL is to pre-
vent Ca2+ overload during rapid atrial rate where the
Ca2+ concentration in atrial myocytes is substantial-
ly increased [2]. Studies have also reported reduced
transient outward current (Ito) in both canine [20]
and human [17] models of AF, and increased back-
ground inward rectifier (IK1) [17, 24]; their clinical
relevance remains unclear however. A concomitant
decrease in sodium current (INa) and conduction
velocity in a canine model of rapid atrial pacing sug-
gested a potential role for INa in the development of
an AF substrate [15]. Interestingly, INa was reported-
ly unchanged in humans with AF compared to
those in sinus rhythm [17]. A handful of studies have
consistently demonstrated an upregulation of a con-
stitutively active form of acetylcholine-dependent
potassium current (IKACh) both in canine and human
myocytes of AF and may be involved in ERP abbre-
viation [17, 25]. Connexins are important in impulse
propagation and their roles in AF have been incon-
sistent in studies. Elvan et al. [26] reported an in-
crease in connexin43 protein expression in dogs
with AF, while Van der Welden et al. [27] found in-
stead a heterogeneously decreased atrial conne-
xin40 distribution in goat models. Although the up-
regulation of both connexin40 and connexin43 have
been observed in the left atrium (LA) tissue of AF
patients, their effects on atrial impulse propagation
remain to be elucidated [28].
A handful of studies have investigated auto-
nomic remodeling in canine models of AF. Studies
using positron emission tomography imaging [29]
and immunocytochemical staining [30] have consis-
tently reported an increased atrial sympathetic
nerve innervation as well as an inhomogeneous
sympathetic innervation in paced dogs compared to
controls.
Atrial remodeling is not a permanent event and
has been shown to be reversible. We conducted this
systematic review to put together the cohort stu-
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dies relevant to reverse atrial electrical remodeling.
To the best of our knowledge, there has been no
previous systematic review discussing or compar-
ing reverse atrial electrical remodeling reported in
various clinical scenarios. We aim to determine the
conditions under which reverse atrial electrical re-
modeling occurs, and its clinical manifestation.
Methods
We performed a systematic search of literature
published on Pubmed and EMBASE database in
English from 1990 up to May 2011, including both
animal and human studies. The terms used for the
search were: “atrial remodeling”, “atrial electrical
remodeling”, “reverse atrial remodeling”, and “re-
verse remodeling”. Two reviewers (HP and AB)
independently screened titles to identify studies
relevant to the topic. Disagreement was solved by
consensus.
Methods to quantify atrial electrical
remodeling and reverse
electrical remodeling
Non-invasive method
Maximum P-wave duration, P-wave dispersion,
and the newly emerged high-resolution signal-
-averaged P-wave (SAPW) assessed using a surface
electrocardiogram are widely accepted non-invasive
markers for atrial electrical remodeling. Atrial con-
duction disturbances are manifested as a prolonga-
tion of P-wave duration. Previously, specific atrial
electrophysiological variables such as atrial ERP
and conduction velocity of atrial impulse could only
be assessed by invasive study. It was not until re-
cently that SAPW analysis was recognized as a non-
invasive tool to provide information on atrial elec-
trophysiology. Redfearn et al. [31] were the first to
correlate surface P-wave parameters and atrial elec-
trophysiology parameters, and acknowledged the
usefulness of SAPW as an evaluation tool for atrial
electrophysiology.
Invasive method
Electrophysiology study is an invasive method
to determine atrial ERP, conduction velocity of atrial
impulse, and vulnerability to AF. Wijffels et al. [1]
and Morillo et al. [4] were the first to demonstrate
atrial electrical remodeling after rapid atrial pacing
in goat and canine models, respectively. The goats
were instrumented with multiple electrodes at the
epicardium of both atria connected to an external
pacemaker; the dogs were paced at 400 bpm for six
weeks using a transvenous lead sutured to the right
atrial appendage. Atrial ERP was determined using
an internal catheter to introduce extrastimuli at de-
creasing coupling intervals until it failed to result
in atrial depolarization. Atrial vulnerability to AF
was assessed in both studies by stimulating the
heart with either multiple extrastimuli or a single
stimulus of four times the threshold.
Results
Our search returned 5,212 articles that were
potentially useful, and ten titles were found rele-
vant to the purpose of the study after careful screen-
ing. Only studies that assessed atrial electrical re-
modeling before and after intervention were includ-
ed. Searching the references of the ten articles
provided another three manuscripts for this review.
Post-cardioversion
We identified five prospective studies that eva-
luated reverse atrial electrical remodeling post-car-
dioversion in patients with AF. Two studies that
measured the SAPW duration at one month [32] and
three months [33] post-cardioversion consistently
reported a significant decrease in those who re-
mained in sinus rhythm, but not in those who re-
curred. The study by Chalfoun et al. [32] showed
a decrease in SAPW from 159 ± 19 to 146 ± 17 ms
(p < 0.0001) in 22 patients at one month, while
Healey et al. [33] reported a shortening from
158 ± 28 to 152 ± 24 ms (p = 0.009) in 44 patients,
but not in the 32 who recurred (164 ± 31 to 158 ±
± 36 ms, p = 0.3). Furthermore, a study by Guo et al.
[34] reported shorter P-wave duration in patients
who remained in sinus rhythm within six months
post-cardioversion compared to those with AF re-
currence (143 ± 17 vs 157 ± 24 ms, p < 0.0001).
Two other studies performed electrophysiologic
testing post-cardioversion and concomitantly re-
ported prolonged atrial ERP at the distal coronary
sinus at four days [35] and one week [36] (p < 0.01).
Consistent with other studies, the latter group also
found a significant decrease of SAPW duration at
one week (135 ± 18 to 129 ± 13 ms, p = 0.04) [36].
The shortening of SAPW duration and prolongation
of atrial ERP represent faster intra-atrial conduc-
tion and provide clear evidence for reverse atrial
electrical remodeling.
Post-ablation
Atrial fibrillation ablation has also been de-
monstrated to be effective in reversing atrial remo-
deling. In a recent study by Tops et al. [37], 112 pa-
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roxysmal AF and 36 persistent AF patients who had
catheter ablation showed a decrease in maximum
LA volume (30 ± 7 to 25 ± 7 mL/m2, p < 0.001)
and an increase in LA total emptying fraction
(41 ± 13 to 45 ± 14%, p = 0.002). Those who
showed > 15% decrease in maximal LA volume
were classified as responders; they demonstrated
significant increases in LA emptying fraction and
LA maximal strain after the ablation. In contrast,
the non-responders showed no changes in LA vo-
lume, emptying fraction, or strain. The recurrences
of AF in responders and non-responders were 12%
and 69% (p < 0.001), respectively. These findings
illustrate the reversal of atrial remodeling, repre-
sented by an improved LA transport and contrac-
tile function. Interestingly, the LA strain was sig-
nificantly lower at baseline in the non-responders,
suggesting that the strain may be a reflection of
structural changes that can indicate the reversibi-
lity of LA remodeling by catheter ablation. In an
earlier study, AF patients who remained in sinus
rhythm after the ablation showed a significant im-
provement in LA emptying fraction (25 ± 13.1 to
30.8 ± 7.9%, p = 0.03) and contractility, and a con-
comitant decrease in LA minimal volume (44.7 ±
± 14.9 to 38.0 ± 11.5 mL/m2, p = 0.04) [38]. These
parameters were unchanged from baseline for those
with AF recurrence. This is consistent with ano-
ther study which also reported a reduction in LA size
only in those successfully restored to sinus rhythm
after linear ablation (48.6 ± 7.6 to 44.8 ± 4.7 mm,
p = 0.0001), but an increase in others (48.2 ± 8.1
to 52.3 ± 7.8 mm, p = 0.001) [39]. A comparison
of reverse atrial remodeling in catheter ablation
and electrical cardioversion was conducted by Choi
et al. [40]. They found that both atrial defibrilla-
tion methods resulted in a significant reduction in
LA size at three months. However, improvement
in LA function at three months, represented by
LA ejection fraction, was observed after cardiover-
sion (31.4 ± 9.5 to 39.5 ± 9.1%, p = 0.004), but not
after ablation (31.8 ± 12.8 to 30.9 ± 10%, p = 0.64).
Post-cardiac resynchronization therapy
Cardiac resynchronization therapy (CRT), also
known as biventricular pacing, is the optimal treat-
ment for patients with advanced heart failure. Yu
et al. [41] reported an improved atrial contractile
function and compliance in a study of 107 heart fail-
ure patients who received CRT for three months.
Only those defined as responders, who demonstrat-
ed a reduction of left ventricular end-systolic volu-
me of > 10% after CRT, showed an improvement
in LA wall contraction velocity (3.6 ± 1.8 to 4.5 ±
± 1.9 cm/s vs 3.2 ± 1.8 to 3.5 ± 1.9 cm/s,
p = 0.01) and atrial compliance, as determined by
tissue Doppler velocity and strain imaging. Further-
more, responders reported an increase in LA emp-
tying fraction and a decrease in LA size that were
not observed in the non-responders. This is con-
sistent with another study by Donal et al. [42], who
also reported decreased LA volume (45.5 ± 8.5 to
39.1 ± 9.6 mL/m2, p < 0.001) and increased LA
emptying fraction in responders after six months
of CRT.
Post-mitral commissurotomy
We found one study, by John et al. [43], report-
ing significant reverse atrial electrical remodeling
in patients with mitral stenosis after mitral commis-
surotomy. Patients presented a decrease in LA
volume and mean LA pressure accompanied by
a shortening of P-wave duration (139 ± 19 to 135 ±
± 20 ms, p = 0.047). At long-term follow-up, a re-
duction in atrial ERP at cycle lengths of 600 ms
(p < 0.0001) and 400 ms (p = 0.0001) and further
shortening of P-wave duration to 113 ± 19 ms (p =
= 0.04) were demonstrated. Most importantly,
a trend for reduced vulnerability for AF was shown
by a decrease in the number of patients with sus-
tained AF. These findings suggest that reverse
atrial electrical remodeling may be induced by the
removal of chronic stretch in patients with mitral
stenosis.
Post-continous positive airway pressure
in obstructive sleep apnea patients
Previously, our group reported an increase in
maximum P-wave duration of 7.6 ms and P-wave
dispersion (14.6 ± 7.5 vs 8.9 ± 3.1 ms, p < 0.001)
in moderate-severe obstructive sleep apnea (OSA)
patients compared to controls, illustrating atrial
electrical remodeling associated with the disease
[44]. No studies have assessed the potential of con-
tinuous positive airway pressure (CPAP) treatment
to reverse these changes. However, our group re-
cently found a shortening of SAPW duration from
131.9 ± 10.4 ms to 126.2 ± 8.8 ms (p < 0.001) af-
ter four to six weeks of CPAP in 19 severe OSA
patients, an indication of improved atrial conduction
and reverse electrical remodeling [45].
Discussion
Since its introduction in 1995, numerous stu-
dies in animal and human models have emerged to
characterize atrial electrical remodeling. The find-
ings have contributed significantly to our under-
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standing of the pathophysiology underlying the ini-
tiation and maintenance of AF.
While reverse structural remodeling has been
extensively studied, evidence on reverse electrical
remodeling is currently limited. We were only able
to identify a handful of relevant studies. Nonethe-
less, they concomitantly showed that reverse atrial
electrical remodeling is manifested as reduced
SAPW or P-wave duration, prolonged atrial ERP,
and reduced vulnerability to AF, often accompanied
by reduced LA size and improved LA function.
In the setting of post-cardioversion for AF, the
current literature consistently reports a prolonga-
tion of atrial ERP and shortening of P-wave dura-
tion only in those who remain in sinus rhythm, not
in those who recur. Reductions of as much as 6 ms
by one week [36] and 13 ms by one month [32] have
been reported. Interestingly, reverse electrical re-
modeling was not observed in those who recurred,
highlighting the relationship between reverse re-
modeling and AF recurrence.
In post-ablation, studies concurrently report-
ed significant improvement in LA emptying fraction
and reduction in LA size, only in those successful-
ly restored to sinus rhythm. The improvement in
atrial conduction post-ablation may improve atrial
function, subsequently contributing to the mainte-
nance of sinus rhythm.
Studies on post-cardioversion and post-ablation
suggest that reverse atrial electrical remodeling
occurs only in successfully defibrillated patients,
and that improvements in atrial conduction and
atrial function are related. It has been suggested
that a certain amount of reverse atrial electrical
remodeling must occur to sufficiently prevent the
recurrence of AF. However, it remains unclear
whether reverse remodeling is the cause or the con-
sequence of the maintenance of sinus rhythm.
A couple of studies have shown that CRT in
heart failure patients improved atrial contractile
function and LA emptying fraction. Changes in
P-wave duration or atrial ERP, if any, have yet to
be systematically investigated. The enhanced LA
function may be the consequence of improved atrial
conduction allowing better co-ordination of atrial
cardiomyocytes. But this interpretation requires
further prospective studies.
The only study of mitral commissurotomy in
patients with mitral stenosis reported reduced
P-wave duration and AF propensity, further streng-
thening the relationship between atrial remodeling
and vulnerability to AF.
Our group has shown a reduction in SAPW
duration in patients with severe OSA treated with
CPAP (Fig. 1). The resolution of intermittent hy-
poxemia and hypercapnia may remove the triggers
Figure 1A–D. Sample signal average P-wave (SAPW) analyses for a severe obstructive sleep apnea (OSA) subject
(upper panels) and a control subject (lower panels). At first (left) and second (right) SAPW recording; x-axis — [ms];
y-axis — [µV]. The area in gray represents the average P-wave of 100 beats. There is a reduction of SAPW duration
after four to six weeks of continuous positive airway pressure (CPAP) in the subject with severe OSA, but no change
in SPAW duration in the control case.
630
Cardiology Journal 2011, Vol. 18, No. 6
www.cardiologyjournal.org
that cause atrial electrical remodeling, thereby improv-
ing atrial conduction. There was a positive correlation
between the reduction of the apnea/hypopnea index
and the shortening of the SAPW. These findings also
suggest that the underlying disease may need to be tar-
geted to reverse atrial electrical remodeling.
Conclusions
The concept of reverse atrial electrical remo-
deling is intriguing. A full understanding of it holds
the prospect of tremendous clinical value in reduc-
ing the morbidity associated with AF. Further stu-
dies of reverse atrial electrical remodeling consist-
ing of larger populations in different clinical scena-
rios are warranted. The findings will shed light on
determining the best treatment option for patients
at risk of AF.
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